Supervisory Board
Fresenius Medical Care AG & Co. KGaA




Dr. Dorothea Wenzel
Supervisory Board
Darmstadt, Germany
In her role as Lead Independent Director, Dr. Dorothea Wenzel is responsible for addressing environmental, social and governance (ESG) aspects on the Supervisory Board as well as to develop and propose measures on such aspects.


CVs are updated on an ongoing basis, but at least once a year.
Profile of skills and expertise and concrete objectives for the composition
Pursuant to recommendation C.1 of the German Corporate Governance Code, the Supervisory Board of Fresenius Medical Care AG & Co. KGaA has determined concrete objectives for its composition and prepared a profile of skills and expertise for the entire Supervisory Board. The Supervisory Board will take into consideration such objectives and profile of skills and expertise when discussing its election proposals to the General Meeting.
Rules of Procedure
In accordance with the recommendation D.1 of the German Corporate Governance Code, the Supervisory Board has adopted rules of procedure which set out, among other things, the modalities for convening meetings and the manner in which resolutions are adopted.
Supervisory Board Committees
From the midst of its members, the Supervisory Board forms qualified committees for the efficient exercise of its responsibilities, which prepare the matters for deliberation and resolutions of the Supervisory Board. The Supervisory Board regularly and timely receives briefings on the committees’ work.
Audit and Corporate Governance Committee
- Pascale Witz (Chair)
- Dr. Dorothea Wenzel (Vice Chair)
- Rolf A. Classon
Nomination Committee
- Dr. Dieter Schenk (Chairman)
- Rolf A. Classon (Vice Chairman)
- Dr. Dorothea Wenzel
Joint Committee
Fresenius Medical Care AG & Co. KGaA also has established a Joint Committee whose composition and activity is provided for in Articles 13a et seq. of the Articles of Association of the Company. The Joint Committee is convened only as required, namely in cases of certain legal transactions defined in the Articles of Association as substantial transactions and for which the General Partner requires the consent of the Joint Committee.
Members of Fresenius Medical Care AG & Co. KGaA
- Dr. Dorothea Wenzel (Vice Chairman)
- Rolf A. Classon
Members of Fresenius Medical Care Management AG
- Michael Sen (Chairman)
- Sara Hennicken
Lead Independent Director and ESG expertise
With the introduction of the role of a Lead Independent Director, the Supervisory Board of Fresenius Medical Care AG & Co. KGaA has further strengthened its corporate governance and independence. In addition, the Supervisory Board thus underscores its commitment to support and drive Fresenius Medical Care’s global sustainability management – and to align its own mandate even more closely to sustainability matters.
To develop and maintain a balanced understanding of their issues and concerns, the Lead Independent Director is available for discussions with shareholders and other stakeholders within the framework of the statutory regulations. The Lead Independent Director role specifically includes responsibility to address matters relating to environmental, social and governance (ESG) aspects and to develop and propose measures on such ESG aspects.
Dr. Dorothea Wenzel has been appointed as Lead Independent Director on May 20, 2021 and has in-depth ESG expertise. This includes the areas of reporting and regulation, ESG strategies and initiatives, and the formulation of ESG targets. Dr. Wenzel regularly participates in external trainings to further deepen her existing knowledge and stay informed about current developments. In close exchange with the Global Sustainability team, she has familiarized herself with the structures, processes and focus areas of Fresenius Medical Care's sustainability management.
The Lead Independent Director is a member of the Audit and Corporate Governance Committee and of the Nomination Committee of the Supervisory Board and has the right to convene meetings and to set agenda items in accordance with the Rules of Procedure of the Supervisory Board. The Lead Independent Director is appointed from among the members of the Supervisory Board and shall not hold any executive position or supervisory mandate in Fresenius SE & Co. KGaA, its general partner, its major shareholder or any of its subsidiaries other than the mandate in the supervisory board of Fresenius Medical Care AG & Co. KGaA.

As Supervisory Board of Fresenius Medical Care AG & Co. KGaA it is our goal to ensure that all legitimate interests are considered adequately to the benefit of the Company and its stakeholders. It is therefore my key priority to support the sustainable development of the company in order to create lasting value – economically, ecologically and socially.
Fresenius Medical Care Management AG,
General Partner of Fresenius Medical Care AG & Co. KGaA
Supervisory Board
Michael Sen
Chairman
Dr. Dieter Schenk
Vice Chairman
Rolf A. Classon
Sara Hennicken
Gregory Sorensen, MD
Pascale Witz
Supervisory Board Committees
From the midst of its members, the Supervisory Board forms qualified committees for the efficient exercise of its responsibilities, which prepare the matters for deliberation and resolutions of the Supervisory Board. The Supervisory Board regularly and timely receives briefings on the committees’ work.
Human Resources Committee
- Michael Sen (Chairman)
- Dr. Dieter Schenk (Vice Chairman)
- Rolf A. Classon
Nomination Committee
- Michael Sen (Chairman)
- Dr. Dieter Schenk (Vice Chairman)